Table 2:

Transfusion data and plasma wastage during study protocols

VariableFixed-ratio group n = 37Control group n = 32Difference (95% CI)*p value
Transfusion data
Ratio of RBC:FP:PLT achieved, median (IQR)1 : 1 : 1 (1 to 1.3 : 1 : 0.8 to 1.3)1.7 : 1 : 0.8 (1.2 to 2.3 : 1 : 0.5 to 1.3)RBC: −0.7 (−1.1 to −0.3)
PLT: 0.2 (−0.3 to 0.35)
RBC: < 0.01
PLT: 0.3
Received 1:1:1 ratio, no. (%)21 (57)2 (6)51 (32 to 68)< 0.01
Received only RBC:FP at 1:1 ratio, no. (%)27 (73)7 (22)51 (31 to 71)< 0.01
Total no. of RBC:FP:PLT units per patient,§ median (IQR)7 : 6 : 8 (6 to 10 : 4 to 8 : 4 to 8)7 : 4 : 4 (6 to 14 : 3 to 8 : 0 to 8)RBC: 0 (−5 to 2.5)
FP: 2 (0 to 4)
PLT: 4 (−3 to 6)
RBC: 0.6
FP: 0.07
PLT: 0.1
Received FP transfusion, no. (%)36 (97)26 (81)16.0 (1.5 to 30.5)0.04
Received PLT transfusion, no. (%)34 (92)21 (66)26.3 (7.6 to 44.9)0.01
Received massive transfusion (≥ 10 RBC units in 24 h), no. (%)15 (41)15 (47)−6.3 (−29.8 to 17.1)0.6
Time to first RBC, min, median (IQR)25.5 (14 to 48.5)32.5 (13 to 70.5)−7.0 (−23.5 to 13.5)0.8
Time to first FP, min, median (IQR)89 (65 to 150)113 (81 to 165)−24 (−60 to 9)0.05
Time from first RBC to first FP, min, median (IQR)60 (40 to 77)78 (49 to 112)−19 (−45 to −1)0.05
Plasma wastage
Total FP units thawed, no.390289NANA
FP units wasted, no. (%)86 (22)30 (10)NANA
  • Note: CI = confidence interval, FP = frozen plasma, IQR = interquartile range, NA = not applicable, PLT = platelets, RBC = red blood cells, SD = standard deviation.

  • * For continuous data, estimation of the 95% CI for the median difference between the 2 groups was calculated using the bootstrap technique based on 10 000 simulations.

  • χ2 test or Fisher exact test to compare proportions; Wilcoxon rank-sum test to compare distributions; p values for differences in RBC, FP and PLT utilization between study groups are reported separately.

  • Ratios of RBC:FP and FP:PLT calculated to 1 FP unit. One patient in the fixed-ratio group and 4 in the control group did not receive any FP; p values for the differences in RBC:FP and FP:PLT ratios between study groups are reported separately.

  • § Absolute number of units of RBC, FP and PLT transfused per patient during study protocols.

  • Time from hospital arrival to transfusion of first unit of RBC or FP; the time was not recorded for 1 patient in the fixed-ratio group.